Frank Pasqualone

Insider Reports History

Entity
Individual
Location
901 Gateway Blvd, South San Francisco, CA
Signature
/s/ Bradley J. Wyatt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Pasqualone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. SVP, CHIEF BUSINESS OFFICER Ordinary Shares 430K $4.42M $10.29 Nov 19, 2021 Direct
Enveric Biosciences, Inc. Director Common Stock 1K Sep 15, 2023 Direct

Insider Reports Filed by Frank Pasqualone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENVB Enveric Biosciences, Inc. Sep 15, 2023 1 $2.14K 4 Sep 19, 2023 Director
ENVB Enveric Biosciences, Inc. Jul 13, 2022 0 $0 3 Jul 22, 2022 Director
TBPH Theravance Biopharma, Inc. Nov 19, 2021 1 -$31.6K 4 Nov 23, 2021 SVP, CHIEF BUSINESS OFFICER
TBPH Theravance Biopharma, Inc. Aug 20, 2021 1 -$53.1K 4 Aug 24, 2021 SVP, Chief Business Officer
TBPH Theravance Biopharma, Inc. May 20, 2021 1 -$67.3K 4 May 24, 2021 SVP, Chief Business Officer